Insider Transactions in Q1 2025 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 04
2025
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,759
-2.71%
|
$54,529
$31.7 P/Share
|
Mar 04
2025
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,002
+8.47%
|
-
|